A new drug being trialled for treating breast cancer and diabetes has been shown to ‘melt away’ the fat inside arteries that can cause heart attacks and strokes.
Researchers from the University of Aberdeen, using pre-clinical mouse models, showed that just a single dose of the drug (Trodusquemine) completely reversed the effects of a disease that causes a host of heart problems.
Atherosclerosis is the build-up of fatty material inside the arteries.
Over time this fatty material can grow bigger until your arteries become so narrow that not enough blood can pass through.
Atherosclerosis is the condition that causes most heart attacks and strokes.
In pre-clinical tests, mice with set-in atherosclerosis, mimicking what happens in humans, had less fatty plaques in their arteries whether they had regular doses over time or just a single dose of Trodusquemine.
The drug works by stopping an enzyme called PTP1B, which is normally increased in people with obesity or diabetes and conditions involving prolonged inflammation such as sepsis, inflamed diabetic foot ulcers and allergic lung inflammation. The researchers found that it also stimulated the action of another protein (AMPK), which effectively mimics exercise and reduces chronic inflammation.
It has already been shown to be effective with diabetes and breast cancer patients but this is the first time the drug has been shown to have benefits for long-term cardiovascular disease.
The £236,000 study was funded by the British Heart Foundation.
Professor Mirela Delibegovic and Dr Dawn Thompson from the University of Aberdeen’s Institute of Medical Sciences who led the study said: “All humans have some level of atherosclerosis. As you age you start to develop these fatty streaks inside your arteries. It is a big problem for people who are overweight or have underlying cardiovascular conditions.”
“Trodusquemine has already been trialled for treatment of diabetes and breast cancer but this is the first time it has been used in models of atherosclerosis.
“These have only been tested at pre-clinical level, in mice, so far but the results were quite impressive and showed that just a single dose of this drug seemed to completely reverse the effects of arthrosclerosis.
“The next step is to test the ability of this drug to improve outcomes in human patients with developed atherosclerosis and cardiovascular disease”.
Learn more: Drug ‘melts away’ fat inside arteries
The Latest on: Atherosclerosis
- In-hospital recurrence in a Chinese large cohort with acute ischemic strokeon October 18, 2019 at 2:14 am
The independent risk factors for in-hospital recurrence included large artery atherosclerosis, urinary or respiratory infection and abnormal blood glucose, whereas recurrence was less likely to occur ...
- Central Venous Catheters Market to Reach USD 2,234.1 Million by 2026 | Reports And Dataon October 17, 2019 at 5:05 pm
NEW YORK, Oct. 17, 2019 /PRNewswire/ -- The rise in prevalence of cardiovascular diseases such as atherosclerosis, arrhythmias, coronary artery disease, Myocarditis, pericarditis, myocardial ...
- Sheriff says outage did not kill man who collapsed 12 minutes after oxygen tank lost poweron October 11, 2019 at 10:36 pm
A 67-year-old Pollock Pines man who breathed with the help of an oxygen tank that required electricity died 12 minutes after power was cut in a planned PG&E shut-off Wednesday, but an autopsy ...
- Better quality 'good' cholesterol may fight atherosclerosis in diabeteson October 1, 2019 at 12:04 am
Healthline Media, Inc. would like to process and share personal data (e.g., mobile ad id) and data about your use of our site (e.g., content interests) with our third party partners (see a current ...
- "Good" Cholesterol Counters Atherosclerosis in Mice with Diabeteson September 30, 2019 at 12:27 pm
NEW YORK, Sept. 30, 2019 /PRNewswire/ -- Increasing levels of a simplified version of "good" cholesterol reversed disease in the blood vessels of mice with diabetes, a new study finds. Published ...
- ‘Good’ cholesterol counters atherosclerosis in mice with diabeteson September 30, 2019 at 5:51 am
Published online in the journal Circulation on September 30, the study results revolve around atherosclerosis, a condition where high levels of cholesterol cause “plaques” to form in vessel walls, ...
- 'Good' cholesterol counters atherosclerosis in mice with diabeteson September 29, 2019 at 5:00 pm
Increasing levels of a simplified version of 'good' cholesterol reversed disease in the blood vessels of mice with diabetes. Published online in the journal Circulation on September 30, the study ...
- Mummies show atherosclerosis was prevalent in ancient timeson September 24, 2019 at 2:16 pm
They are thought to be from the period 2000 BC to 1000 AD. The study looked for any evidence that these people had suffered arterial damage due to atherosclerosis. This is a term that refers to the ...
via Google News and Bing News